Skip to content

Timing of Re-evaluation After Steps I-II of Periodontal Therapy

Timing of Re-evaluation After Steps I-II of Periodontal Therapy: a Randomized Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05892315
Enrollment
60
Registered
2023-06-07
Start date
2023-05-11
Completion date
2024-12-11
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Brief summary

Literature on non surgical periodontal therapy (NSPT) shows lack of clarity in reporting information on re-evaluation timing and clinical response. If the re-evaluation was done shortly after NSPT, this is also likely to have an influence on the surgical treatment plan. The aim of this randomized clinical trial is to investigate the effect of re-evaluation timing at 1-3-6 months after NSPT in terms of pocket closure, probing pocket depth reduction, comprehensive treatment plan, and costs for the patient.

Interventions

PROCEDURERepeated subgingival instrumentation

Supragingival scaling will be performed at sites with plaque and subgingival scaling will be performed by the use of manual and ultrasonic instruments at pockets ≥ 4 mm with bleeding. Oral hygiene instructions will be reinforced. Patients will be instructed to use interdental brushes with appropriate size interdental brushes or dental floss when interdental embrasures will not allow for interdental brushing.

PROCEDURESupragingival scaling

Supragingival scaling will be performed at sites with plaque. Oral hygiene instructions will be reinforced. Patients will be instructed to use interdental brushes with appropriate size interdental brushes or dental floss when interdental embrasures will not allow for interdental brushing.

Sponsors

University of Turin, Italy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Periodontitis stage III-IV * Full-mouth plaque score (FMPS) \< 25% at the 1-month re-evaluation * Full-mouth bleeding score (FMBS) \< 25% at the 1-month re-evaluation * Signed informed consent

Exclusion criteria

* Age \< 18 yo * Pregnancy or lactation * Heavy smokers (\>10 die) * Conditions or diseases influencing periodontal healing * Patients that cannot complete the 6 months follow-up

Design outcomes

Primary

MeasureTime frameDescription
Change in treatment success % (0 - 100 % with higher percentage indicating better status)Baseline, 1 month, 3 months and 6 months after the completion of the therapy.Percentage of pockets ≥ 4 mm with bleeding that converted to ≤ 3 mm or ≤4 mm without bleeding at the completion of non-surgical periodontal therapy

Secondary

MeasureTime frameDescription
Change in Full Mouth Plaque Score (FMPS%) (0 - 100 % with higher percentage indicating worse status)Baseline, 1 month, 3 months and 6 months after the completion of the therapy.Percentage of full mouth plaque score considering 6 sited for each tooth.
Change in Probing Pocket Depth (PD) (0 - 15 mm with higher values indicating worse outcomes).Baseline, 1 month, 3 months and 6 months after the completion of the therapy.The distance between the cementoenamel junction (CEJ) and the base of the pocket.
Change in Clinical Attachment Level (CAL) (0 - 15 mm with higher values indicating worse outcomes).Baseline, 1 month, 3 months and 6 months after the completion of the therapy.The sum of Probing pocket depth (PD, mm) and Recession (Rec, mm).

Countries

Italy

Contacts

Primary ContactMario Aimetti, Professor
mario.aimetti@unito.it00390116331541

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026